Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results

Last Modified: 5/17/2007 First Published: 4/1/1998


1.		Phase II Randomized Study of ISIS 5132 or ISIS 3521 in Women With Previously Treated Metastatic Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				ECOG-3197 NCT00003236, E3197

Last Modified: 8/1/1999 First Published: 5/1/1998


2.		Phase II Study of ISIS 5132 in Patients with Advanced Pancreatic Cancer (Summary Last Modified 08/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				E-3297 E3297

Last Modified: 7/1/1999 First Published: 8/1/1998


3.		Phase II Randomized Study of ISIS 3521 and ISIS 5132 in Patients with Hormone Refractory Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								CAN-NCIC-IND111 IND111

Last Modified: 12/1/1999 First Published: 8/1/1998


4.		Phase II Randomized Study of ISIS 3521 and ISIS 5132 for Locally Advanced or Metastatic Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								CAN-NCIC-IND112 IND112

Last Modified: 7/1/2000 First Published: 7/1/1999


5.		Phase II Study of ISIS 5132 in Patients With Recurrent Ovarian Epithelial Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								CAN-NCIC-IND116 NCT00003892, IND116

Last Modified: 1/1/2000 First Published: 9/1/1999


6.		Phase II Study of ISIS 5132 in Patients with Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer or Recurrent Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Pharmaceutical / Industry				EORTC-16978 ISIS-EORTC-16978

Select All on One Page